Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microstaging in cutaneous melanoma.

D J Ruiter, A Spatz, J J van den Oord

    The Journal of Pathology
    |December 18, 2001
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma.

    Lung cancer (Amsterdam, Netherlands)·2019
    Same author

    A Canadian guideline on the use of next-generation sequencing in oncology.

    Current oncology (Toronto, Ont.)·2019
    Same author

    Evidence-based best practices for <i>EGFR</i> T790M testing in lung cancer in Canada.

    Current oncology (Toronto, Ont.)·2018
    Same author

    How iMALDI can improve clinical diagnostics.

    The Analyst·2018
    Same author

    Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2018
    Same author

    Radiological imaging of teratological fetuses: what can we learn?

    Insights into imaging·2017
    Same journal

    Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights.

    The Journal of pathology·2026
    Same journal

    Lipodystrophy and adipose tissue recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.

    The Journal of pathology·2026
    Same journal

    Optical mapping reveals a higher level of large-scale structural variants in a family with paternally transmitted myotonic dystrophy and independent Parkinson's disease.

    The Journal of pathology·2026
    Same journal

    FTO-mediated m6A modification of protein disulfide-isomerase activates VEGFA-VEGFR2 to suppress programmed cell death in osteosarcoma.

    The Journal of pathology·2026
    Same journal

    Dopamine inhibits retinal pathological neovascularization in the oxygen-induced retinopathy mouse model.

    The Journal of pathology·2026
    Same journal

    Aberrant alternative splicing of purinergic receptor P2RX4 prevents sensitivity towards combinatorial treatment in colorectal and pancreatic cancer.

    The Journal of pathology·2026
    See all related articles

    New research discusses critical updates in cutaneous melanoma microstaging, including the American Joint Committee on Cancer (AJCC) staging proposal and novel prognostic models. These advancements offer improved accuracy for clinical practice and patient outcomes in melanoma diagnosis.

    Area of Science:

    • Dermatopathology and Oncology
    • Cancer Staging and Prognostics

    Background:

    • Recent literature highlights significant challenges and advancements in the microstaging of cutaneous melanoma.
    • The American Joint Committee on Cancer (AJCC) has proposed a new staging system impacting melanoma classification.
    • Emerging prognostic models show potential for practical application in daily clinical settings.

    Discussion:

    • The EORTC Melanoma Group's Pathology Committee provides commentary on these critical developments.
    • New immunohistochemical findings offer prognostic information beyond traditional factors.
    • Integration of these findings may refine current melanoma management strategies.

    Key Insights:

    • The AJCC's revised staging proposal for cutaneous melanoma requires careful consideration.

    Related Experiment Videos

  • Novel prognostic models demonstrate promise for enhanced patient risk stratification.
  • Immunohistochemistry provides valuable prognostic data independent of established criteria.

    • Outlook:

    • Further validation of new prognostic models is essential for widespread clinical adoption.
    • The incorporation of immunohistochemical markers could personalize melanoma treatment.
    • Continued dialogue and research are crucial for advancing melanoma microstaging and patient care.